dc.contributor.author | Blix, Egil Støre | |
dc.contributor.author | Irish, Jonathan M. | |
dc.contributor.author | Husebekk, Anne | |
dc.contributor.author | Delabie, Jan | |
dc.contributor.author | Forfang, Lise | |
dc.contributor.author | Tierens, Anne | |
dc.contributor.author | Myklebust, June | |
dc.contributor.author | Kolstad, Arne | |
dc.date.accessioned | 2013-03-13T12:39:02Z | |
dc.date.available | 2013-03-13T12:39:02Z | |
dc.date.issued | 2012 | |
dc.description.abstract | Knowledge about signaling pathways in malignant cells may provide prognostic and diagnostic information in addition to identify potential molecular targets for therapy. B-cell receptor (BCR) and co-receptor CD40 signaling is essential for normal B cells, and there is increasing evidence that signaling via BCR and CD40 plays an important role in the pathogenesis of B-cell lymphoma. The aim of this study was to investigate basal and induced signaling in lymphoma B cells and infiltrating T cells in single-cell suspensions of biopsies from small cell lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) and marginal zone lymphoma (MZL) patients.
Samples from untreated SLL/CLL and MZL patients were examined for basal and activation induced signaling by phospho-specific flow cytometry. A panel of 9 stimulation conditions targeting B and T cells, including crosslinking of the B cell receptor (BCR), CD40 ligand and interleukins in combination with 12 matching phospho-protein readouts was used to study signaling.
Malignant B cells from SLL/CLL patients had higher basal levels of phosphorylated (p)-SFKs, p-PLCγ, p-ERK, p-p38, p-p65 (NF-κB), p-STAT5 and p-STAT6, compared to healthy donor B cells. In contrast, anti-BCR induced signaling was highly impaired in SLL/CLL and MZL B cells as determined by low p-SFK, p-SYK and p-PLCγ levels. Impaired anti-BCR-induced p-PLCγ was associated with reduced surface expression of IgM and CD79b. Similarly, CD40L-induced p-ERK and p-p38 were also significantly reduced in lymphoma B cells, whereas p-p65 (NF-κB) was equal to that of normal B cells. In contrast, IL-2, IL-7 and IL-15 induced p-STAT5 in tumor-infiltrating T cells were not different from normal T cells.
BCR signaling and CD40L-induced p-p38 was suppressed in malignant B cells from SLL/CLL and MZL patients. Single-cell phospho-specific flow cytometry for detection of basal as well as activation-induced phosphorylation of signaling proteins in distinct cell populations can be used to identify aberrant signaling pathways. | en |
dc.description | This paper is part of Egil Støre Blix' ph.d thesis which is available in Munin at <a href=http://hdl.handle.net/10037/7755>http://hdl.handle.net/10037/7755</a> | en |
dc.identifier.citation | BMC Cancer (2012), vol. 12 (478) | en |
dc.identifier.cristinID | FRIDAID 999685 | |
dc.identifier.doi | http://dx.doi.org/10.1186/1471-2407-12-478 | |
dc.identifier.issn | 1471-2407 | |
dc.identifier.uri | https://hdl.handle.net/10037/4997 | |
dc.identifier.urn | URN:NBN:no-uit_munin_4675 | |
dc.language.iso | eng | en |
dc.publisher | BioMed Central | en |
dc.rights.accessRights | openAccess | |
dc.subject | VDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Medical molecular biology: 711 | en |
dc.subject | VDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Medisinsk molekylærbiologi: 711 | en |
dc.title | Phospho-spesific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma | en |
dc.type | Journal article | en |
dc.type | Tidsskriftartikkel | en |
dc.type | Peer reviewed | en |